Expert Rev Neurother. 2009;9(12):1713-1725. The first patients with squint were successfully treated in 1977 [17] and since then botulinum toxin type A delivered by local injection has been used in ...
Interim data from the ongoing EPITOME trial1 showed that 45.7% of stroke survivors with paresis developed post-stroke spasticity within 1 year<1% of stroke survivors receive BoNT-A treatment for ...
A advancement in the diagnosis of upper limb (UL) spasticity is on the horizon, moving beyond traditional reliance on clinicians' tactile assessments. Researchers affiliated with UNIST have developed ...
Complete list of Ipsen presentations at TOXINS 2026: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results